NeuroOne Medical Technologies Corporation (NMTC) Earnings History
Annual and quarterly earnings data from 2010 to 2025
Loading earnings history...
NMTC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NMTC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 67.3% | -34.9% | -29.8% |
| 2024 | 31.3% | -344.3% | -356.7% |
| 2023 | 23.4% | -612.3% | -607.4% |
| 2022 | -41.4% | -5860.2% | -5842.0% |
| 2021 | -54.9% | -5735.9% | -5584.3% |
Download Data
Export NMTC earnings history in CSV or JSON format
Free sign-in required to download data
NeuroOne Medical Technologies Corporation (NMTC) Earnings Overview
As of May 8, 2026, NeuroOne Medical Technologies Corporation (NMTC) reported trailing twelve-month net income of -$7M, reflecting +80.4% year-over-year growth. The company earned $-0.81 per diluted share over the past four quarters, with a net profit margin of -29.8%.
Looking at the long-term picture, NMTC's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6,044 in fiscal 2010.
NeuroOne Medical Technologies Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including LIVN ($107M net income, -17.5% margin), NVCR (-$173M net income, -20.8% margin), MDT ($4.61B net income, 13.9% margin), NMTC has room to improve margins relative to the peer group. Compare NMTC vs LIVN →
NMTC Earnings vs Peers
Earnings metrics vs comparable public companies
NMTC Historical Earnings Data (2010–2025)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$4M | +70.7% | -$4M | $-0.54 | -29.8% | -34.9% |
| 2024 | -$12M | -3.9% | -$12M | $-2.76 | -356.7% | -344.3% |
| 2023 | -$12M | -18.6% | -$12M | $-3.90 | -607.4% | -612.3% |
| 2022 | -$10M | -0.5% | -$10M | $-3.78 | -5842.0% | -5860.2% |
| 2021 | -$10M | +27.1% | -$10M | $-5.58 | -5584.3% | -5735.9% |
| 2020 | -$14M | -101.1% | -$5M | $-15.12 | -708.0% | -254.5% |
| 2019 | -$7M | +0.7% | -$6M | $-10.32 | - | - |
| 2018 | -$7M | -35.0% | -$3M | $-14.58 | - | - |
| 2017 | -$5M | -10488.0% | -$3M | $-13.80 | - | - |
| 2016 | $-47,775 | +24.0% | $-32,611 | $-0.17 | - | - |
See NMTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NMTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NMTC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNMTC — Frequently Asked Questions
Quick answers to the most common questions about buying NMTC stock.
Is NMTC growing earnings?
NMTC EPS is $-0.81, with earnings growth accelerating to +80.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-7M.
What are NMTC's profit margins?
NeuroOne Medical Technologies Corporation net margin is -29.8%, with operating margin at -34.9%. Below-average margins reflect competitive or cost pressures.
How consistent are NMTC's earnings?
NMTC earnings data spans 2010-2025. The accelerating earnings trend is +80.4% YoY. Historical data enables comparison across business cycles.